Congress Park Capital LLC Biogen Inc. Transaction History

Congress Park Capital LLC

$269 Million
Q3 2024

A detailed history of Congress Park Capital LLC transactions in Biogen Inc. stock. As of the latest transaction made, Congress Park Capital LLC holds 2,505 shares of BIIB stock, worth $395,539. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,505

Previous 2,783 9.99%

Holding current value

$395,539

Previous $645,000 24.81%

% of portfolio

0.18%

Previous 0.26%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$189.07 - $236.8 $52,561 - $65,830	-278 Reduced 9.99%	2,505 $485,000
Q2 2024 Jul 12, 2024	SELL	$190.52 - $236.72 $162,894 - $202,395	-855 Reduced 23.5%	2,783 $645,000
Q1 2024 Apr 15, 2024	SELL	$212.02 - $267.71 $101,557 - $128,233	-479 Reduced 11.63%	3,638 $784,000
Q4 2023 Jan 19, 2024	SELL	$222.59 - $267.94 $207,231 - $249,452	-931 Reduced 18.44%	4,117 $1.07 Million
Q3 2023 Oct 13, 2023	BUY	$253.3 - $285.89 $1.28 Million - $1.44 Million	5,048 New	5,048 $1.3 Million
Q2 2022 Jul 22, 2022	SELL	$187.54 - $223.02 $267,244 - $317,803	-1,425 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$193.77 - $244.14 $62,975 - $79,345	-325 Reduced 18.57%	1,425 $300,000
Q4 2021 Feb 09, 2022	BUY	$223.92 - $287.77 $167,940 - $215,827	750 Added 75.0%	1,750 $420,000
Q3 2021 Nov 03, 2021	BUY	$282.99 - $369.05 $282,990 - $369,050	1,000 New	1,000 $283,000
Q1 2021 Apr 19, 2021	SELL	$242.95 - $284.63 $340,130 - $398,482	-1,400 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$236.26 - $355.63 $330,764 - $497,882	1,400 New	1,400 $343,000
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $523,006 - $576,502	-2,385 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$216.71 - $338.96 $250,300 - $391,498	-1,155 Reduced 32.63%	2,385 $564,000
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $16,710 - $21,165	-60 Reduced 1.67%	3,540 $1.07 Million
Q3 2018 Oct 29, 2018	SELL	$293.51 - $383.83 $2,935 - $3,838	-10 Reduced 0.28%	3,600 $1.27 Million
Q2 2018 Aug 06, 2018	BUY	$257.52 - $306.91 $6,438 - $7,672	25 Added 0.7%	3,610 $1.05 Million
Q1 2018 Apr 17, 2018	SELL	$260.13 - $367.91 $78,039 - $110,373	-300 Reduced 7.72%	3,585 $982,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $1.2 Million - $1.34 Million	3,885	3,885 $1.24 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Congress Park Capital LLC with notifications on news.

Account

Congress Park Capital LLC Biogen Inc. Transaction History